Valve in valve transcatheter aortic valve implantation (ViV-TAVI) versus redo-Surgical aortic valve replacement (redo-SAVR): A systematic review and meta-analysis.
Nikhil NalluriVarunsiri AttiAbdullah B MunirBoutros KaramNileshkumar J PatelVarun KumarPraveen VemulaSushruth EdlaDeepak AstiAmrutha PaturuSriramya GayamJonathan SpagnolaEmad BarsoumGregory A ManiatisFrank TamburrinoRuben KandovJames LaffertyChad KligerPublished in: Journal of interventional cardiology (2018)
Our results reiterate the safety and feasibility of ViV-TAVI for failed aortic BP valves in patients deemed to be at high risk for surgery. VIV-TAVI was associated with lower risk of permanent pacemaker implantation with a trend toward increased risk of paravalvular leak.
Keyphrases
- aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve
- aortic stenosis
- ejection fraction
- transcatheter aortic valve replacement
- left ventricular
- end stage renal disease
- newly diagnosed
- minimally invasive
- peritoneal dialysis
- coronary artery bypass
- coronary artery disease
- mitral valve
- patient reported outcomes
- acute coronary syndrome
- atrial fibrillation